Trial Profile
An open label, retrospective trial to evaluate the efficacy of zonisamide in patients with migraine who are non-responsive to topiramate
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Oct 2015
Price :
$35
*
At a glance
- Drugs Zonisamide (Primary)
- Indications Migraine without aura
- Focus Therapeutic Use
- 23 Oct 2015 New trial record